BrainStorm files to sell 2.76M shares of common stock for holders

* BrainStorm Cell Therapeutics (NASDAQ:BCLI [https://seekingalpha.com/symbol/BCLI]) filed to sell 2.76M shares of common stock for holders.
* This prospectus is not an offer to sell.
* Filing [https://seekingalpha.com/filing/10128008]

MORE ON BRAINSTORM CELL THERAPEUTICS

* Brainstorm Cell Therapeutics outlines imminent Phase 3b ALS trial launch following FDA clearance and expanded manufacturing plans [https://seekingalpha.com/news/4450103-brainstorm-cell-therapeutics-outlines-imminent-phase-3b-als-trial-launch-following-fda]
* Seeking Alpha’s Quant Rating on BrainStorm Cell Therapeutics [https://seekingalpha.com/symbol/BCLI/ratings/quant-ratings]
* Historical earnings data for BrainStorm Cell Therapeutics [https://seekingalpha.com/symbol/BCLI/earnings]